Gary L. Disbrow, PhD

Dr. Gary L. Disbrow is the Deputy Assistant Secretary and the Director of the Center for the Biomedical Advanced Research and Development Authority (BARDA), a component of the Administration for Strategic Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services (HHS). BARDA invests in the innovation, advanced research and development, acquisition, and manufacturing of medical countermeasures – vaccines, drugs, therapeutics, diagnostic tools, and non-pharmaceutical products - needed to combat health security threats. BARDA has established hundreds of public-private sector partnerships.

Dr. Disbrow joined BARDA in January of 2007 and has held a variety of positions related to the advanced development and procurement of medical countermeasures against an array of threats to national security and public health. Prior to becoming the BARDA Director, Dr. Disbrow served as acting BARDA Director, Deputy Assistant Secretary of ASPR, and the Office of Medical Countermeasures Program Director. Prior to joining BARDA, Dr. Disbrow was an Assistant Professor of Oncology and Pathology at Georgetown Medical Center where he worked on human papillomavirus (HPV) vaccines and therapeutics. Dr. Disbrow has previously worked at W.R. Grace, Kodak, and Genecor. Dr. Disbrow attended the University of Rochester and Georgetown University for his undergraduate degree and Ph.D. respectively.